Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response | GenomeWeb

Click here to register … | Learn More About Workshops and More. Photo Credit/Source: (C) Concierge Medicine Today, LLC/The DocPreneur Leadership Podcast/Academy

By Staff Reporter, GenomeWeb, July 7, 2022

NEW YORK – Epigenetic changes to the promoter regions of BRCA1 appear to have a different effect on treatment response than genomic alterations in BRCA1 or BRCA2 in triple-negative breast cancer (TNBC) or ovarian carcinoma patients, new research suggests.


Related Reference: Science Translational Medicine; Jul 6 2022 Vol 14, Issue 652 DOI: 10.1126/scitranslmed.abn192

READ MORE at Science Translational Medicine Here …


Next Post

Use of Short-Course Radiation Therapy for Lymphomas | JAMA Health Forum

Thu Jul 7 , 2022
JAMA Health Forum EMBARGOED […]

Breaking News